These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8475324

  • 1. Alprazolam in panic disorder: a retrospective analysis.
    Shelton RC, Harvey DS, Stewart PM, Loosen PT.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):423-34. PubMed ID: 8475324
    [Abstract] [Full Text] [Related]

  • 2. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE, Kraus M.
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [Abstract] [Full Text] [Related]

  • 3. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC.
    J Psychiatr Res; 1993 Feb; 27 Suppl 1():155-70. PubMed ID: 8145176
    [Abstract] [Full Text] [Related]

  • 4. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [Abstract] [Full Text] [Related]

  • 5. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ, Harmatz JS, Shader RI.
    Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC, Swinson RP, Kuch K, Lewis CP.
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [Abstract] [Full Text] [Related]

  • 11. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study.
    Sheehan DV, Raj AB, Harnett-Sheehan K, Soto S, Knapp E.
    Acta Psychiatr Scand; 1993 Jul; 88(1):1-11. PubMed ID: 8372689
    [Abstract] [Full Text] [Related]

  • 12. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M.
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
    Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A.
    Am J Psychiatry; 1994 Jun; 151(6):876-81. PubMed ID: 8184997
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.